Breaking News
December 15, 2017 - For marketplace customers who delay, auto-enrollment could be nasty wake-up
December 15, 2017 - Researchers identify potential alternatives to tackle drug resistant malaria parasites
December 15, 2017 - Scientists unravel mystery of how immune cells remember infections decades later
December 15, 2017 - Outcomes Poorer for Black Patients with Early Breast Ca
December 15, 2017 - Liposuction May Ease Limb Swelling in Cancer Patients
December 15, 2017 - How well can digital assistants answer questions on sex?
December 15, 2017 - NIH-funded study to explore hearing loss risk in Detroit firefighters
December 15, 2017 - Caris Life Sciences reveals identification of new mechanism of action to treat NHL
December 15, 2017 - Loyola Medicine study finds high success rate for diabetic Charcot foot surgery
December 15, 2017 - Bone marrow edema does not increase due to intense physical activity, study finds
December 15, 2017 - Human ‘common cold’ virus kills healthy chimpanzees in Uganda
December 15, 2017 - Experience of reflex walking refines perception of biological motion during early infancy
December 15, 2017 - FDA Approves Admelog (insulin lispro) Rapid-Acting “Follow-On” Insulin Product to Treat Diabetes
December 14, 2017 - Friday Feedback: Good Idea for Ex-Pharma Exec to Run HHS?
December 14, 2017 - More than 200 people sickened onboard Ovation of Seas cruise
December 14, 2017 - FDA announces new approach for sharing updates on antibiotics, antifungal drugs to physicians
December 14, 2017 - Steroid study provides new insights into medicines’ side effects
December 14, 2017 - Government announces plans to include eye test reminder during driving license renewal
December 14, 2017 - Non-ionizing radiation from magnetic fields could have adverse biological impacts on health
December 14, 2017 - Bi-annual MRI beats mammograms in detecting breast cancer among women with genetic risk
December 14, 2017 - Researchers develop new method for quickly detecting signs of multiple sclerosis
December 14, 2017 - In era of increased competition, hospitals fret over ratings
December 14, 2017 - Female veterans experience improvement in low back pain with course of chiropractic care
December 14, 2017 - Relieving Symptoms of Cystic Fibrosis with Exercise
December 14, 2017 - FDA Alert: Blue Pearl All Natural Male Enhancement Supplement: Recall
December 14, 2017 - CardioBrief: In Defense Of ORBITA
December 14, 2017 - Definition of High Blood Pressure Drops: MedlinePlus Health News
December 14, 2017 - Drug may help surgical patients stop opioids sooner
December 14, 2017 - Researchers develop biosensor that enables development of new health tests
December 14, 2017 - Radiation therapy can be used to treat patients with life-threatening heart rhythm
December 14, 2017 - UVA researchers developing tool to help prostate cancer patients weigh treatment options
December 14, 2017 - Experts tell Congress how to cut drug prices
December 14, 2017 - Researchers use cryptographic techniques to decode activity of motor neurons
December 14, 2017 - Study finds changes in the heart after spinal cord injury
December 14, 2017 - Health Highlights: Dec. 12, 2017
December 14, 2017 - Pelzman’s Picks: How States Can Cut Disparities in Care and Costs
December 14, 2017 - New Hemophilia Treatment Stems Bleeding Episodes: MedlinePlus Health News
December 14, 2017 - Onetime ‘world’s heaviest man’ has second surgery in Mexico
December 14, 2017 - Belgian researchers create transplantable artificial ovary prototype
December 14, 2017 - Using atraumatic needles for lumbar punctures decreases risk of complications
December 14, 2017 - Outpatient total knee replacement surgery linked to higher rates of complications
December 14, 2017 - Social impairments can be corrected by brain stimulation
December 14, 2017 - Studies reveal possibility for memory T cells to serve a dual purpose
December 14, 2017 - Antibody-Drug Conjugate Ups PFS in Untreated Hodgkin’s
December 14, 2017 - Study finds reading information aloud to yourself improves memory
December 14, 2017 - Researchers use RNA nanotechnology to program exosomes for delivering effective cancer therapies
December 14, 2017 - Living Lyme disease bacteria found months after antibiotic treatment
December 14, 2017 - These annual checkups help seniors not only survive but thrive
December 14, 2017 - Study reveals impact of diabetes during pregnancy on baby’s heart
December 14, 2017 - Hydraulic fracturing is harmful to infants health, study states
December 14, 2017 - Huntington’s disease drug clears initial hurdles
December 14, 2017 - TPU researchers create 3D-printed models of children’s hearts
December 14, 2017 - Brain responses of children with inherited dyslexia risk predict their future reading speed
December 14, 2017 - People diagnosed with schizophrenia or bipolar disorder may actually have treatable condition
December 14, 2017 - Study: New Furosemide Formulation Simplifies Administration for HF
December 14, 2017 - Discrimination harms your health—and your partner’s
December 14, 2017 - Having older brothers may increase the likelihood of being gay
December 14, 2017 - New scientific yardstick released to help early detection of Alzheimer’s disease
December 14, 2017 - New finding demonstrates what happens at cellular level during onset of type2 diabetes
December 14, 2017 - Study identifies potassium as key to circadian rhythms in red blood cells
December 14, 2017 - Good friends might be your best brain booster as you age
December 14, 2017 - NIH expected to award up to $70 million to launch Alzheimer’s Clinical Trials Consortium
December 14, 2017 - Pitting pathogens against each other could prevent drug resistance emerging
December 14, 2017 - Study provides new insights into development of Sonic Hedgehog medulloblastoma
December 14, 2017 - Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis
December 14, 2017 - Gene Screens Can Alter Perception, Behavior
December 14, 2017 - Can Scrotal Vein Condition Hike Heart Risks?: MedlinePlus Health News
December 14, 2017 - Molecules in spit may be able to diagnose and predict length of concussions
December 14, 2017 - Children’s Colorado and RxRevu partner to help prescribers better meet needs of pediatric patients
December 14, 2017 - Researchers discover new way to attack drug-resistant prostate cancer cells
December 14, 2017 - Scientists develop new, high resolution method for identifying microbial species and strains
December 14, 2017 - Declining trend of salmonellosis cases has leveled off in the EU
December 14, 2017 - Death receptors in the blood can help measure risk of cardiovascular diseases, type 2 diabetes
December 14, 2017 - How to Perk Up the Holidays for Hospital Patients
December 14, 2017 - Prolonged Sedation May be Bad for Baby’s Brain
December 14, 2017 - The pediatric submersion score predicts children at low risk for injury following submersions
December 14, 2017 - Video game helps doctors to quickly recognize trauma patients who need high levels of care
December 14, 2017 - Younger persons newly-diagnosed with type 2 diabetes have poorer health than older patients
December 14, 2017 - Clinician re-examines evidence on re-use of catheters and UTIs in people with spinal cord injuries
December 14, 2017 - UK and Russian researchers join forces against AMR
Using AFM to characterize cancer cells

Using AFM to characterize cancer cells

image_pdfDownload PDFimage_print

An interview with Dr. Jim Gimzewski, UCLA conducted by April Cashin-Garbutt, MA (Cantab)

Can you please give a brief introduction to your research characterizing cancer cells?

My name is James Gimzewski and I am a distinguished professor at UCLA. I’m in the Chemistry and Biochemistry department, but I am also heavily involved in the California NanoSystems Institute at UCLA. We were probably the first to pioneer the idea of what is now known as mechanobiology – the study of the mechanical properties of cancer cells as a potential diagnostic tool.

Credit: Mikheiken, A. et al. DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle. Nat Commun. 8, 1665 (2017)

How has AFM allowed you to measure cell softness and why is this important?

One of the beautiful things about AFM is that it is a mechanical tool. In the same way a doctor would feel the skin or tissue of a patient, AFM allows that to be done on the nanoscale and it is unique in that respect.

What challenges did you have to overcome in terms of making sure the cells didn’t burst?

We know a lot about AFM technology. At the beginning, AFM was not very good at biology at all. However, we are experts in nanotechnology and by working with people who are experts in cells, and bringing the two fields together, we could conduct a lot of research and decrease forces, for instance, and understand things about the tip, which enabled us to develop this ability.

Mechanobiology and AFM from AZoNetwork on Vimeo.

 

Is it known why metastatic cancer cells are extremely soft compared to normal cells despite similarities in appearance?

I work with people at UCLA who are experts in pathology and there are subtle differences in certain morphologies and so on in cancer cells, but it is not always possible to tell that.

We have an orthogonal tool that when used to look at the mechanobiology, shows us that the metastatic cancer cells are about 10 times softer than some equivalent mesothelial cells that would be in a sample.

Will it be possible to use AFM in the clinical environment as a diagnostic tool?

I have been working with Jianya Rao who is the head of pathology and specializes in cancer diagnosis. Together, we are working on a new type of tool, which is an automated platform that would allow, for instance, medical people to use the microscope and automatically detect cancer cells. That is the long-term goal of our work − being able to translate that into a medical setting.

How has AFM directly advanced or helped your research?

I have always been interested in nanomechanics. I started studying nanotechnology in 1983 at IBM and then I moved to UCLA in 2001. I started to think we could use this nanomechanical tool as a unique way of looking at biology and that led me into medicine. It is an essential tool and it keeps improving by getting faster and more automated. I have a rosy view for the future of its use in medicine.

What is the biggest impact that AFM has made to the biological and nanomedicine research fields?

There are numerous ones. Of course, I particularly like the ability to study mechanobiology, but I am also interested in imaging and high-speed AFM. We have been able to image molecular motors running along actin filaments. High speed allows you to take videos of life at the nanoscale and I think they are marvelous. More things will emerge in the future.

Credit: Mikheiken, A. et al. DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle. Nat Commun. 8, 1665 (2017)

How has Bruker technology helped or advanced AFM in biological research?

They are one of the leading companies, particularly in the bio field. Personally, together with the California NanoSystems Institute, we have a very close relationship. They are in Santa Barbara and we are in Los Angeles.

They go out of their way to tweak and modify the machine according to who is working in bio and medical needs. I think that has been a very important aspect and, in particular, Chanmin Su is an absolute wizard at putting things together in a very short space of time!

What is the importance of meetings, like the AFM BioMed Conference, to you and the AFM research community?

Just today, I have learned so much. I try to keep up with the literature. In the old days, there were perhaps 50 AFM researchers in the world, whereas today, there are thousands of AFM researchers. This is therefore a great opportunity to get together, talk to people, find out the latest developments and even come up with new ideas and ideas for collaboration.

This is a particularly good meeting. It is also not too big; it doesn’t have parallel sessions and so on, so you can really have a one-to-one relationship with a lot of the people who are talking here or presenting posters.

What direction do you see, or would like to see, AFM going in the next five years? What do you see as the next big thing for AFM?

I would like to see a couple of things. I would like to see the speed keep increasing. At the moment, just some small demonstrations have shown 1,000 frames a second is possible under certain conditions, but it would be good if under all biological conditions, we could have really fast videos and watch the mechanics of life in motion. I think that is one direction.

The other direction concerns the fact that AFMs tend to be general purpose. They can look at cells and at strands of DNA. They can do lots of things, but that comes at a price. I would like to see more purpose-built AFMs − ones that can map DNA and are designed for that high speed. In the field of medical diagnosis, it would be useful to have machines that are much easier to operate so that a medical technician could run them.

A third direction that is important to me is to keep reducing the forces down to piconewtons. We typically talk about nanonewtons in AFM, but I would like to see a move to very low perturbations in terms of the forces.

Those are the three things that I personally would like to see happen and I think they will happen.

Where can readers find more information?

About Dr. Jim Gimzewski

Dr. James K. Gimzewski is a distinguished professor of Chemistry at the University of California, Los Angeles and member of the California NanoSystems Institute. His current research includes nanoscale science of biological systems, fabrication of atomic switch networks to emulate the neocortex and the mechanobiology of cells, exosomes and actin bound with neuronal binding proteins.

Dr. Gimzewski is a Fellow of the Royal Society and Royal Academy of Engineering. He has received honorary Doctorates (DSc hc & PhD hc) from the University of Aix II in Marseille, France and from the University of Strathclyde, Glasgow. He is a PI at Materials Nanoarchitectonics  (MANA)  in the National Institute of Materials Science (NIMS), Tsukuba, Japan. He is also Scientific director of the UCLA Art|Sci Center.

Prior to joining the UCLA faculty in 2001, he was a group leader at IBM Zurich Research Laboratory, where he conducted research in nanoscale science and technology for more than 18 years. Dr. Gimzewski pioneered research on mechanical and electrical contacts with single atoms and molecules using scanning tunneling microscopy (STM).

Tagged with:

About author

Related Articles